ÖZET Giriş: Adenoid kistik karsinom (AKK), memenin nadir görülen neoplazmlarındandır. Tüm meme karsinomlarının %0.1'ini oluşturmaktadır. AKK'lar memede izlenen diğer histolojik alt tiplerine göre çok iyi prognoza sahiptirler. Uzak metastaz ve lenf nodu tutulumu çok nadirdir. Sıklıkla östrojen reseptörü (ER), progesteron reptörü (PR) ve c-erbB2 durumu negatif olarak tespit edilmektedir. Olgu: Kırksekiz yaşında premenapozal kadın hasta sol memede ele gelen kitle nedeniyle doktora başvurmuş. Hastaya memedeki lezyon için tru-cut biyopsi uygulandı. Biyopsi sonucunun AKK olarak gelmesi üzerine hastaya modifiye radikal mastektomi operasyonu uygulandı. Operasyon materyalinin patolojik incelemesi orta derecede diferansiye AKK ile uyumlu olarak tespit edildi. Tümör boyutu 4.8 cm ve aksiller diseksiyon sonucu 48 lenf nodu negatif olarak tespit edildi. Tümörün immünohistokimyasal özellikleri triple negatif (ER, PR ve cerbB2) olarak değerlendirildi. Sonuç: AKK'ler çoğunlukla ER(-), PR(-) ve c-erbB2 (-) durumu ile ender görülen meme karsinomlarıdır. AKK'ler nadir görülen meme karsinomları olduğundan ve yeterli klinik çalışma bulunmadığından tedavi opsiyonları sınırlıdır. Anahtar Kelimeler: Meme neoplazm; adenoid kistik karsinom; iyi prognoz ABSTRACT Background: Adenoid cystic carcinoma (ACC), one of the rarest neoplasia of the breast, constitutes 0.1% of all breast carcinomas. The prognosis of ACC is very good compared to other histological subtypes of breast carcinoma. Lymph node involvement and distant metastasis are very infrequent. Estrogen receptor (ER), progesterone receptor (PR) and c-erbB2 (also known as HER-2/neu) are typically negative. Case Report: A fourty eight year-old premenauposal women was admitted to hospital with a mass on the upper outer quadrant of her left breast. Since the result of through-cut biopsy of this suspicious lesion was consistent with adenoid cystic carcinoma, modified radical mastectomy with axillary lymph node excision was applied. Pathological examination revealed a moderately differantiated adenoid cystic carcinoma of the breast. The size of invasive tumor component was 4.8 cm in its greatest dimension. Immunohistochemical analysis was consistent with triple negative phenotype (ER,PR and c-erbB2 negative). Conclusion: ACC is a rare type of human breast carcinoma with ER, PR and c-erbB2 negative phenotype. They usually show an excellent prognosis however there is no well defined treatment options for ACC since the rarity of clinical studies in such kind of unusual histological subtypes of breast carcinomas.
Background
Adenoid cystic carcinoma (ACC), one of the rarest neoplasia of the breast, constitutes 0.1% of all breast carcinomas (1) . The prognosis of ACC is very good compared to other histological subtypes of breast carcinoma. ACC of the breast is commonly seen in perimenapausal patients. The median age at the time of diagnosis is usually at the 5 th and 6 th decades (2) . Although mostly located subareolar area of the breast, nipple and/or skin changes are rarely encountered. Lymph node involvement and distant metastasis are very infrequent (3). Estrogen receptor (ER), progesterone receptor (PR) and c-erbB2 (also known as HER-2/neu) are typically negative.
Case Report
A fourty eight year-old premenauposal woman ACC cases are usually defined in perimenapausal women in their 5th to 6th decades however ACC in men was very rarely reported in the literature (5). ACC is mostly observed in the subareolar site of breast. Nipple and skin changes are seldomly involved (5) . In the presented case however, the tumor was in the upper outer quadrant. Besides, nipple or skin changes were also not a feature of this case.
Although fine needle biopsy was enough to recommend for the diagnosis, in the presented case, a tru-cut biopsy was applied. In the literature, the average size of invasive tumor of ACC patients was reported to be 2 cm but varied greately from 0.2 cm to 12 cm (2) . In the presented case, the tumor size was 4.8 cm.
ACC cases are mostly presented with the IHC phenotype of triple negative or basal like breast cancer as ER, PR and c-erbB2 negative (6) . Pathological criteria of ACC involves biphasic cellular pattern consists of basaloid myoepithelial cells together with ductal epithelial cells (7) . In the presented case, a triple negative phenotype was detected. ACC of the breast was reported to have an excellent prognosis because of the rare Adressforcorrespondence: Uzm. Dr. Onur Esbah e-mali: onurilyasoglu131202@yahoo.com Available at www.actaoncologicaturcica.com Copyright ©Ankara Onkoloji Hastanesi tendency of lymph node involvement and distant metastasis. If distant metastasis occurs, it usually appears before axillary involvement (3). The most common site of distant metastasis are the lungs. Arpino et al. found only four cases of lymph node metastasis in a review of 182 cases and 14 distant metastasis without lymph node involvement (2) . Since the rarity of lymph node metastasis, axillary dissection is usually not recommended. Local excision, simple mastectomy or MRM are the curative treatments of choice.
Ro et al. recomended local excision without axillary disection for grade I tumors (without solid components in the tumor), simple mastectomy for grade II tumors (<30% solid components in the tumor) and MRM for grade III tumors (>30% solid components in the tumor) (8), but also radiotherapy for cases treated by local excision and simple mastectomy in other study (9) .
There are reports to suggest adjuvant chemotherapy for ACC in the literature (10) . However, there is no specific adjuvant chemotherapy recommendation for favorable histological subtypes of breast carcinoma including ACC cases. Besides, there has been no randomised clinical trials to guide changing adjuvant treatment of these better natured and uncommon histological subtypes of breast cancers. ACC is a rare subtype of breast carcinomas with triple negative or basal-like features. They usually have an excellent outcome, however specific adjuvant treatment for this subtype of breast carcinoma is not standard yet because of lack of randomised controlled studies.
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